MYCN and Nijmegen breakage syndrome: Reactivation of RORα could significantly improves the anti-tumor activity of etoposide and serve as a therapeutic strategy for MYCN-amplified NBs by blocking the dysregulation of molecular clock and cell metabolism mediated by MYCN (Moreno-Smith et al., 2021).